Nikolett Marton

Nikolett Marton

Auto-generated profile, based on publicly available information

Nikolett Marton

Department of Radiology, Medical Imaging Centre, Semmelweis University, Budapest, Hungary

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 December 2015 in PLOS ONE
Verified
Journal Article
Open access
PDF file
TBTamás Baranyai
Tamás Baranyai
KHKata Herczeg
Kata Herczeg
ZGZsofia Gulyas-Onodi
Zsofia Gulyas-Onodi
IVIstván Voszka
István Voszka
KMKároly Módos
Károly Módos
ZGZoltán Giricz
Zoltán Giricz
Exosomes are emerging targets for biomedical research. However, suitable methods for the isolation of blood plasma-derived exosomes without impurities have not yet been described. Therefore, we investigated the efficiency and purity of exosomes isolated with potentially suitable methods; differential ultracentrifugation (UC) and size exclusion chromatography (SEC). Exosomes were isolated from rat and human blood plasma by various UC and SEC conditions. Efficiency was investigated at serial UC of the supernatant, while in case of SEC by comparing the content of exosomal markers of various fractions. Purity was assessed based on the presence of albumin. We found that the diameter of the majority of isolated particles fell into the size range of exosomes, however, albumin was also present in the preparations, when 1h UC at 4°C was applied. Furthermore, with this method only a minor fraction of total exosomes could be isolated from blood as deduced from the constant amount of exosomal markers CD63 and TSG101 detected after serial UC of rat blood plasma samples. By using UC for longer time or with shorter sedimentation distance at 4°C, or UC performed at 37°C, exosomal yield increased, but albumin impurity was still observed in the isolates, as assessed by transmission electron microscopy, dynamic light scattering and immunoblotting against CD63, TSG101 and albumin. Efficiency and purity were not different in case of using further diluted samples. By using SEC with different columns, we have found that although a minor fraction of exosomes can be isolated without significant albumin content on Sepharose CL-4B or Sephacryl S-400 columns, but not on Sepharose 2B columns, the majority of exosomes co-eluted with albumin. Here we show that it is feasible to isolate exosomes from blood plasma by SEC without significant albumin contamination albeit with low vesicle yield.

28 October 2015 in Cellular and Molecular Life Sciences
Verified
Journal Article
Closed access
PDF file
EBEszter Baricza
Eszter Baricza
VTViola Tamási
Viola Tamási
NMNikolett Marton
Nikolett Marton
EBEdit I. Buzás
Edit I. Buzás
György NagyGyörgy Nagy
György Nagy

1 January 2015 in Mediators of Inflammation
Verified
Journal Article
Open access
PDF file
NMNikolett Marton
Nikolett Marton
EBEszter Baricza
Eszter Baricza
BÉBarbara Érsek
Barbara Érsek
EBEdit I. Buzás
Edit I. Buzás
György NagyGyörgy Nagy
György Nagy
Although Src‐like adaptor proteins (SLAP‐1 and SLAP‐2) were mainly studied in lymphocytes, where they act as negative regulators and provide fine control of receptor signaling, recently, several other functions of these proteins were discovered. In addition to the well‐characterized immunoregulatory functions, SLAP proteins appear to have an essential role in the pathogenesis of type I hypersensitivity, osteoporosis, and numerous malignant diseases. Both adaptor proteins are expressed in a wide variety of tissues, where they have mostly inhibitory effects on multiple intracellular signaling pathways. In this review, we summarize the diverse effects of SLAP proteins.

1 March 2023 in Diagnostic and Interventional Radiology
Verified
Journal Article
Open access
NMNikolett Marton
Nikolett Marton
JGJanos Gyebnar
Janos Gyebnar
KFKinga Fritsch
Kinga Fritsch
JMJudit Majnik
Judit Majnik
György NagyGyörgy Nagy
György Nagy
PMPál Maurovich-Horvat
Pál Maurovich-Horvat
Interstitial lung disease (ILD) accounts for a significant proportion of mortality and morbidity in patients with rheumatoid arthritis (RA). The aim of this cross-sectional study is to evaluate the performance of novel photon-counting detector computed tomography (PCD-CT) in the detection of pulmonary parenchymal involvement. Sixty-one patients with RA without a previous definitive diagnosis of ILD underwent high-resolution (HR) (0.4 mm slice thickness) and ultra-high-resolution (UHR) (0.2 mm slice thickness) PCDCT examination. The extent of interstitial abnormalities [ground-glass opacity (GGO), reticulation, bronchiectasis, and honeycombing] were scored in each lobe using a Likert-type scale. Total ILD scores were calculated as the sum of scores from all lobes. Reticulation and bronchiectasis scores were higher in the UHR measurements taken compared with the HR protocol [median (quartile 1, quartile 3): 2 (0, 3.5) vs. 0 (0, 3), P < 0.001 and 2 (0, 2) vs. 0 (0, 2), P < 0.001, respectively]; however, GGO and honeycombing scores did not differ [2 (2, 4) vs. 2 (2, 4), P = 0.944 and 0 (0, 0) vs. 0 (0, 0), P = 0.641, respectively]. Total ILD scores from both HR and UHR scans showed a mild negative correlation in diffusion capacity for carbon monoxide (HR: r = -0.297, P = 0.034; UHR: r = -0.294, P = 0.036). The pattern of lung parenchymal involvement did not differ significantly between the two protocols. The HR protocol had significantly lower volume CT dose index [0.67 (0.69, 1.06) mGy], total dose length product [29 (24.48, 33.2) mGy*cm] compared with UHR scans [8.18 (6.80, 9.23) mGy, P < 0.001 and 250 (218, 305) mGy*cm, P < 0.001]. UHR PCD-CT provides more detailed information on ILD in patients with RA than low-dose HR PCDCT. HR PCD-CT image acquisition with a low effective radiation dose may serve as a valuable, low-radiation screening tool in the selection of patients for further, higher-dose UHR PCD-CT screening.

26 June 2025 in Imaging
Verified
Journal Article
Open access
PDF file
SHSirus S. Hosseini-Begtary
Sirus S. Hosseini-Begtary
AGAnna Gurabi
Anna Gurabi
PHPeter Hegedus
Peter Hegedus
NMNikolett Marton
Nikolett Marton
This review explores the advancements in artificial intelligence for radiograph fracture diagnosis, emphasizing technological developments and inherent limitations. Artificial intelligence improves diagnostic accuracy and manages workflow efficiency. The review categorizes artificial intelligence applications in fracture diagnosis into four primary tasks: recognition, classification, detection, and localization. The most popular performance metrics, such as diagnostic accuracy, precision, sensitivity, specificity, and area under the curve analysis, are used to compare artificial intelligence systems with traditional radiological methods and are explained as serving as a guide. Each task and performance metric is illustrated with practical examples and success stories from recent literature, offering insights into the strengths and weaknesses of various artificial intelligence approaches, such as support vector machines, convolutional neural networks, and generative adversarial networks. We also incorporate case analyses, underscoring the potential and limitations of artificial intelligence in fracture detection. In particular, challenges were posed by external factors such as casts and anatomical complexities. Future directions are explored, emphasizing human-artificial intelligence collaboration and the development of more advanced, transparent artificial intelligence systems alongside parallel evolving ethical considerations and regulatory frameworks. This review aims to equip clinicians with the knowledge to understand and utilize artificial intelligence technologies effectively in their practice.

Verified
Journal Article
Open access
PDF file
OKOrsolya Tünde Kovács
Orsolya Tünde Kovács
ESEszter Soltész-Katona
Eszter Soltész-Katona
NMNikolett Marton
Nikolett Marton
EBEszter Baricza
Eszter Baricza
László HunyadyLászló Hunyady
László Hunyady
György NagyGyörgy Nagy
György Nagy
(1) Adeno-associated viruses (AAV) are safe and efficient gene therapy vectors with promising results in the treatment of several diseases. Extracellular vesicles (EV) are phospholipid bilayer-surrounded structures carrying several types of lipids, proteins, and nucleic acids with the ability to cross biological barriers. EV-associated AAVs might serve as new and efficient gene therapy vectors considering that they carry the benefits of both AAVs and EVs. (2) We tested vesicle-associated AAVs and vesicles mixed with AAVs on two major cell types of the central nervous system: a neural cell line (N2A) and primary astrocyte cells. (3) In contrast to previously published in vivo observations, the extracellular vesicle packaging did not improve but, in the case of primary astrocyte cells, even inhibited the infection capacity of the AAV particles. The observed effect was not due to the inhibitory effects of the vesicles themselves, since mixing the AAVs with extracellular vesicles did not change the effectiveness. (4) Our results suggest that improvement of the in vivo efficacy of the EV-associated AAV particles is not due to the enhanced interaction between the AAV and the target cells, but most likely to the improved delivery of the AAVs through tissue barriers and to the shielding of AAVs from neutralizing antibodies.